BridgeBio 药 BBIO
$74.29 +$0.02 (+0.03%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $74.36 +0.09%
开盘$74.21
昨收$74.27
当日区间$73.19 – $75.70
成交量3.16M
市值$14.47B
市盈率（TTM）–
股息率–
BBIO 相关新闻
匹配 BridgeBio Pharma 或代码 BBIO 的头条新闻，按最新排序。
- Barclays Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $157
- TD Cowen Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $110
- BridgeBio (BBIO.US) cardiac therapy acoramidis outperforms Pfizer’s (PFE.US) competitor drug in real-world study
- Evercore Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $130
- H.C. Wainwright Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $120
- A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $110 to $157
- Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $115
- Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $111
- William Blair Maintains BridgeBio Pharma(BBIO.US) With Buy Rating
- RBC Capital Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $100
- A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $94 to $157
- A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $94 to $115
- Analysts Are Bullish on These Healthcare Stocks: Sagimet Biosciences, Inc. Class A (SGMT), BridgeBio Pharma (BBIO) 正面
- A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $97 to $115
- Jefferies Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $100
暂无评论——快来第一个聊聊 BBIO。
登录后参与讨论。